PPD has a deep understanding of the regulatory drivers, treatment landscape, unmet needs and recruitment strategies across the spectrum of women’s health indications.
Our experience in conducting Phase I-IV and consumer health women’s health studies includes thousands of patients and hundreds of sites across a range of indications with expertise from single-site, dose-exploration studies to multinational outcomes studies. One of our women’s health core functions is designing and conducting pregnancy registries and other studies that evaluate the safety of medicinal products when used during pregnancy.
We are committed to deploying solutions needed to mitigate potential challenges in women’s health clinical trials, including competition for women in clinical trials and site resources, as well as competition with other therapeutic area trials and the reluctance of patients to participate in these studies. We leverage our broad-based site network, targeted training and communication strategies – all with the patient in mind.
Our women’s health team includes more than 1,000 clinical professionals, including board-certified obstetrics/gynecology physicians, reproductive toxicologists, epidemiologists, pharmacologists and nurses who bring extensive clinical trial operational expertise. We provide biopharmaceutical companies a deep understanding of the nuances of the patients’ care journey, their physicians and the practice settings where they seek care.